Research and Clinical Trials

At any given time, approximately 500 clinical trials are occurring at Greenville Health System (GHS) in the areas of oncology, pediatric oncology, women’s health, cardiology and vascular disease. Clinical trials are structured research studies conducted to answer specific questions concerning new therapies, medications, medical devices, vaccines, or new ways of using existing treatment. Trials are sponsored or funded by a variety of organizations from federal agencies to physicians, medical institutions, foundations, and pharmaceutical or medical device companies. This innovative research often results in medical breakthroughs and gives our patients access to the latest treatments, therapies, and medications.

In addition to clinical research, GHS also participates in applied basic science to support the development of new medical devices and drug therapies in the areas of oncology, reproductive endocrinology and vascular surgery.

CONTACT FOR QUESTIONS (PARTICIPANTS)

The consent form that you receive when you are invited to be a research subject includes some contact information if you have questions or concerns about the study.

For more information concerning research study(s) and research-related risks or injuries, or to give comments, concerns or complaints, you may contact a representative of the Institutional Review Board of the Greenville Health System for information regarding your rights as a participant involved in a research.  You may obtain the name and number of this person by calling (864) 455-8997.

A survey about your experience with this informed consent process is located at the following website: https://www.surveymonkey.com/s/XDNMFLV


Participation in the survey is completely anonymous and voluntary and will not affect your relationship with your doctor or the GHS.  

If you would like to have a paper copy of this survey, please tell your study doctor.

RESEARCHERS

The Office of Research Compliance and Administration (ORCA) and the Greenville Health System (GHS) Institutional Review Board (IRB) want to meet their primary responsibility of protecting human subjects who participate in research at GHS. They also want to work in a cooperative and collegial manner with investigators at GHS to assure this protection as a team. Unfortunately, sometimes the best of intent does not always yield the best of results. If you have concerns or complaints about the service you received from the ORCA or one of the IRBs, you have been unable to resolve the problem after direct communication with the ORCA Medical Director, or the IRB, investigators may address concerns and/or suggestions by submitting a written document to the Institutional Official at:

Jerry R. Youkey, MD
Vice President Medical Services and Dean, Academic Services
Telephone:  864-455-7880
Email: jyoukey@ghs.org

The Institutional Official may respond verbally, or in writing, and may take such action as needed to address the concerns and/or suggestions.

Participant Survey: A survey about your experience with this informed consent process.

Participation in the survey is completely anonymous and voluntary and will not affect your relationship with your doctor or the Greenville Health System. If you would like to have a paper copy of this survey, please tell your study doctor.

IRB Member Survey A survey about your experience as an IRB Member.

Participation in the survey is completely anonymous and voluntary and will not affect your relationship with the IRB at Greenville Hospital. If you would like to have a paper copy of this survey, please tell your IRB Coordinator.